| __timestamp | AstraZeneca PLC | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13324000000 | 59644696 |
| Thursday, January 1, 2015 | 11451000000 | 79541000 |
| Friday, January 1, 2016 | 9739000000 | 98015000 |
| Sunday, January 1, 2017 | 10543000000 | 103958000 |
| Monday, January 1, 2018 | 10362000000 | 103654000 |
| Tuesday, January 1, 2019 | 11848000000 | 128951000 |
| Wednesday, January 1, 2020 | 11693000000 | 135799000 |
| Friday, January 1, 2021 | 15680000000 | 149883000 |
| Saturday, January 1, 2022 | 18955000000 | 220206000 |
| Sunday, January 1, 2023 | 18025000000 | 265542000 |
| Monday, January 1, 2024 | 20532000000 |
Cracking the code
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, AstraZeneca PLC and Travere Therapeutics, Inc. have demonstrated contrasting approaches to SG&A cost management. From 2014 to 2023, AstraZeneca's SG&A expenses have fluctuated, peaking in 2022 with a 42% increase from 2016. In contrast, Travere Therapeutics, Inc. has shown a steady rise in SG&A costs, with a notable 345% increase over the same period. This divergence highlights AstraZeneca's ability to scale operations while managing costs, whereas Travere's growth trajectory reflects its expanding market presence. As the pharmaceutical landscape evolves, these companies' strategies in managing operational expenses will be pivotal in shaping their financial health and competitive edge.
Comparing SG&A Expenses: Merck & Co., Inc. vs AstraZeneca PLC Trends and Insights
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Bristol-Myers Squibb Company
AstraZeneca PLC or Bio-Techne Corporation: Who Manages SG&A Costs Better?
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: AstraZeneca PLC vs PTC Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: AstraZeneca PLC vs ImmunityBio, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Travere Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Verona Pharma plc vs Travere Therapeutics, Inc.
Breaking Down SG&A Expenses: MannKind Corporation vs Travere Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc.